0000905148-24-001138.txt : 20240409 0000905148-24-001138.hdr.sgml : 20240409 20240409193208 ACCESSION NUMBER: 0000905148-24-001138 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240405 FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kennedy Lawrence T. Jr CENTRAL INDEX KEY: 0001830773 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39659 FILM NUMBER: 24833911 MAIL ADDRESS: STREET 1: C/O WESTWOOD MANAGEMENT STREET 2: 1700 MADISON ROAD, SUITE 200 CITY: CINCINNATI STATE: OH ZIP: 45206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODESIX INC CENTRAL INDEX KEY: 0001439725 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 203986492 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-417-0500 MAIL ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 4 1 form4.xml X0508 4 2024-04-05 0001439725 BIODESIX INC BDSX 0001830773 Kennedy Lawrence T. Jr 1700 MADISON ROAD, SUITE 200 CINCINNATI OH 45206 true true false Series A Non-Voting Convertible Preferred Stock 2024-04-05 4 A 0 43478 46 A Common Stock 1739120 43478 I By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 Series A Non-Voting Convertible Preferred Stock 2024-04-05 4 A 0 65218 46 A Common Stock 2608720 65218 I By: KFDI-B LLC These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the "Conversion Proposal"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date. /s/ Robin H. Cowie as Attorney-in-Fact for Lawrence T. Kennedy, Jr. 2024-04-09